HomeZYUS • CVE
add
ZYUS Life Sciences Corp
Previous close
$0.70
Year range
$0.55 - $0.94
Market cap
54.61M CAD
Avg Volume
2.71K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 105.00K | -14.63% |
Operating expense | 3.02M | -19.00% |
Net income | -3.62M | 7.50% |
Net profit margin | -3.45K | -8.35% |
Earnings per share | — | — |
EBITDA | -2.30M | 21.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 361.00K | 4.34% |
Total assets | 10.85M | -68.07% |
Total liabilities | 23.82M | 24.75% |
Total equity | -12.97M | — |
Shares outstanding | 80.07M | — |
Price to book | -4.12 | — |
Return on assets | -66.85% | — |
Return on capital | -279.98% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.62M | 7.50% |
Cash from operations | -2.52M | -68.63% |
Cash from investing | -9.00K | 18.18% |
Cash from financing | 2.33M | 129.53% |
Net change in cash | -198.00K | 59.59% |
Free cash flow | -1.34M | -6,185.29% |
About
Founded
2018
Headquarters
Website
Employees
2
